logo-loader
viewScancell Holdings PLC

Scancell Hlds - Price Monitoring Extension

RNS Number : 3865Y
Scancell Holdings Plc
08 September 2020
 

Price Monitoring Extension

The auction call period has been extended in this security by 5 minutes.

Auction call extensions give London Stock Exchange electronic order book users a further opportunity to review the prices and sizes of orders entered in an individual security's auction call before the execution occurs. A price monitoring extension is activated when the matching process would have otherwise resulted in an execution price that is a pre-determined percentage above or below the price of the most recent automated execution today.

The applicable percentage is set by reference to a security's Millennium Exchange sector. This is set out in the Sector Breakdown tab of the Parameters document at www.londonstockexchange.com/tradingservices

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
PMEEASNPEDSEEFA

Quick facts: Scancell Holdings PLC

Price: 14.875

Market: LSE
Market Cap: £109.87 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Morning Report: FTSE 100 on back foot over fears it could take years to find...

Headlines from the Proactive UK newsroom. The FTSE 100 is on the back foot on fears it might take years to find an effective vaccine or treatment against coronavirus. The blue-chip index dropped 70 points to 5,755. Overnight, US firm Gilead Sciences terminated a highly anticipated Chinese...

on 24/4/20